Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III-Reference-Cited by-同舟云学术

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

Published:2005-12 Issue:1 Volume:80 Page:19-32
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

McEvoy Joseph P.,Meyer Jonathan M.,Goff Donald C.,Nasrallah Henry A.,Davis Sonia M.,Sullivan Lisa,Meltzer Herbert Y.,Hsiao John,Scott Stroup T.,Lieberman Jeffrey A.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference50 articles.

1. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older;Alexander;Diabetes,2003

2. Schizophrenia: a life-shortening disease;Allebeck;Schizophrenia Bulletin,1989

3. The distribution of body mass index among individuals with and without schizophrenia;Allison;Journal of Clinical Psychiatry,1999

4. Consensus development conference on antipsychotic drugs and obesity and diabetes;American Diabetes Association;Journal of Clinical Psychiatry,2004

5. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype;Basu;Bipolar Disorders,2004

Cited by 953 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Syndrome and Its Associated Factors Among Patients With Schizophrenia Treated With Second-Generation Antipsychotics at Amanuel Mental Specialized Hospital, Ethiopia;Cureus;2024-09-10

2. Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis;BMC Psychiatry;2024-09-03

3. Metabolic syndrome in psychiatric disorders;Archives of Biological Psychiatry;2024-06-01

4. Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers;Biomedicines;2024-05-10

5. Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials;eClinicalMedicine;2024-05